Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Paul Gass

15PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersCancer diagnosisImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Psychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

Sort by Publication Date:
|Jul 11, 2025
Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial.

Milena Beierlein, Lothar Häberle, Naiba Nabieva

|Oct 14, 2023
Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant Chemotherapy.

Patrik Pöschke, Peter A Fasching, Werner Adler

|Sep 28, 2023
Cytology and HPV Co-Testing for Detection of Vaginal Intraepithelial Neoplasia: A Retrospective Study.

Frederik A Stuebs, Anna K Dietl, Martin C Koch

|Feb 11, 2023
Expression of the Immunohistochemical Markers CK5, CD117, and EGFR in Molecular Subtypes of Breast Cancer Correlated with Prognosis.

Carla E Schulmeyer, Peter A Fasching, Lothar Häberle

|Oct 27, 2022
Concordance Rate of Colposcopy in Detecting Cervical Intraepithelial Lesions.

Frederik A Stuebs, Anna K Dietl, Annika Behrens

|Jul 27, 2022
Cytology and High-Risk Human Papillomavirus Test for Cervical Cancer Screening Assessment.

Frederik A Stuebs, Martin C Koch, Anna K Dietl

Pageof 3

Frequent Collaborators

8 joint publications

Peter A Fasching

4 joint publications

Ramona Erber

3 joint publications

Andreas D Hartkopf

3 joint publications

Joachim Graf

3 joint publications

Elisabeth Simoes

3 joint publications

Lucia Keilmann

3 joint publications

Nina Sickenberger

3 joint publications

Lina Matthies

3 joint publications

Michael P Lux

3 joint publications

Stephanie Wallwiener

Frequent Collaborators

8 joint publications

Peter A Fasching

4 joint publications

Ramona Erber

3 joint publications

Andreas D Hartkopf

3 joint publications

Joachim Graf

Top Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

7.3K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on : Jun 14, 2019

10.4K
See more related videos

Top Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

7.3K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on : Jun 14, 2019

10.4K
See more related videos